Drug Database
Back to search

France· FR:67633828

CIDOFOVIR TILLOMED 75 mg/mL solution à diluer pour perfusion

A cidofovir product containing cidofovir dihydraté, registered in France by TILLOMED PHARMA (ALLEMAGNE). The same ATC class is registered in 15 of our 19 countries.

ATC J05AB12

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedCIDOFOVIR TILLOMED 75 mg/mL solution …ATCJ05AB12REGISTER NO.FR:67633828PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cidofovir dihydratéAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cidofovir is registered in 15 of 19 countries.

Countries holding a registration under ATC J05AB12 (cidofovir), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose
Search cidofovir products by name

Cidofovir · ATC J05AB12

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CIDOFOVIR DIHYDRATÉ
Manufacturer
TILLOMED PHARMA (ALLEMAGNE)
Country
France (FR)
ATC code
J05AB12
ATC class
Cidofovir
Defined daily dose
25 mg, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955079132
    1 flacon(s) en verre de 5 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

70 interactions on record for cidofovir.

Graded by severity as the source publishes them — 59 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cidofovir against other medicinesHow interaction checks work

Cidofovir · interactions on record

70 records

  • 59 severe
  • 11 moderate

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • Amphotericin BA07AA07severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cidofovir in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cidofovir products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Cidofovir Tillomed
  • Belgium · Cidofovir Tillomed
  • Czechia · Cidofovir Tillomed
  • Germany · Cidofovir Tillomed
  • Denmark · Cidofovir Macure
  • Spain · Cidofovir Zentiva
  • Finland · Cidofovir Macure
  • United Kingdom (Northern Ireland) · Cidofovir Tillomed
  • Greece · Cidofovir Tillomed
  • Ireland · Cidofovir Tillomed
  • Italy · Cidofovir Tillomed
  • Netherlands · Cidofovir Tillomed
  • Norway · Cidofovir Macure
  • Poland · Cidofovir Tillomed
  • Portugal · Cidofovir Tillomed
  • Sweden · Cidofovir Macure

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/26555866-cdab-4237-9812-c4e667cf4663
GET /v1/drugs/26555866-cdab-4237-9812-c4e667cf4663?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "67633828",
  "date_amm": "2020-12-28",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "CIDOFOVIR DIHYDRATÉ",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution à diluer pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}
API referenceMCP serverPlans

See everything about cidofovir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console